Search results for “T-Cell Receptor Alpha Chain” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 29 patents, we discovered top 12 key players by total patent application. CRISPR Therapeutics AG, Kirin Brewery Co. Ltd., BGI Shenzhen Co., Ltd. are dominant in this area. They take 51.72% of the total patent filing.
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 2
Kirin Brewery Co. Ltd.
Tokyo-to, Japan
Patent: 2
BGI Shenzhen Co., Ltd.
Guangdong Sheng, China
Patent: 2
Aventis Pharma Ltd.
BERKSHIRE, United Kingdom
Patent: 2
The General Hospital Corp.
Massachusetts, United States
Patent: 1
Kyowa Hakko Kogyo Co., Ltd.
Tokyo-to, Japan
Patent: 1
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 1
Aventis Pharma
Belgium
Patent: 1
Medigene Immunotherapies GmbH
Germany
Patent: 1
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 9 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing CRISPR Therapeutics AG, Jiangsu Quanxin Biomedical Co Ltd, TRON - Translationale Onkologie an der Universitätsmedizin der take 44.44% of patent filing during this period.
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 2
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 1
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 1
Swiss Federal Institute of Technology Zurich
ZURICH, Switzerland
Patent: 1
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 1
Henan Hualong Biotechnology
Henan Sheng, China
Patent: 1
The General Hospital Corp.
Massachusetts, United States
Patent: 1
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 9 patents in last 5 years, we discover 7 new entrants. CRISPR Therapeutics AG, Jiangsu Quanxin Biomedical Co Ltd, TRON - Translationale Onkologie an der Universitätsmedizin der are the most active new entrants in this area.
CRISPR Therapeutics AG
Massachusetts, United States
Patent: 2
STARTUP
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 1
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 1
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 1
Henan Hualong Biotechnology
Henan Sheng, China
Patent: 1
The General Hospital Corp.
Massachusetts, United States
Patent: 1
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 31 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Swiss Federal Institute of Technology Zurich
ZURICH, Switzerland
Patent: 10
Friedrich-Alexander-Universität Erlangen-Nürnberg
Bayern, Germany
Patent: 3
Ludwig-Maximilians-Universität München
Bayern, Germany
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: